Pancreatic Cancer Research

ResearcherFriedrich-Alexander-Universität Erlangen-NürnbergActive in the last 2 years

Eva Lentsch

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5110-0082; OpenAlex author ID A5027736495. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. Roflumilast inhibits tumor growth and migration in STK11/LKB1 deficient pancreatic cancer. Co-author DOI 10.1038/s41420-024-01890-y↗
  2. CRISPR/Cas9-Mediated Knock-Out of Kras G12D Mutated Pancreatic Cancer Cell Lines. Co-author DOI 10.3390/ijms20225706↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Robert Grützmann · 2 shared papers, 2019–2024 · strength 0.25
  2. Christian P. Pilarsky · 2 shared papers, 2019–2024 · strength 0.25
  3. Yanxi Lu · 1 shared paper, 2024 · strength 0.15
  4. Jinping Zhang · 1 shared paper, 2024 · strength 0.15
  5. Hai Yang · 1 shared paper, 2024 · strength 0.15
  6. Duo Yun · 1 shared paper, 2024 · strength 0.15
  7. Bin Lan · 1 shared paper, 2024 · strength 0.15
  8. Nathalie Britzen‐Laurent · 1 shared paper, 2024 · strength 0.15
  9. Hang He · 1 shared paper, 2024 · strength 0.15
  10. Marc P. Stemmler · 1 shared paper, 2024 · strength 0.15
  11. Shuman Zhang · 1 shared paper, 2024 · strength 0.15
  12. Hao Yang · 1 shared paper, 2024 · strength 0.15
  13. Debabrata Mukhopadhyay · 1 shared paper, 2024 · strength 0.15
  14. Andrew Victor Biankin · 1 shared paper, 2024 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.